Literature DB >> 32226618

Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation.

Leana Frankul1, Catherine T Frenette1.   

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-reading-frankul a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-interview-frenette an interview with the author Answer questions and earn https://www.wileyhealthlearning.com/Activity/7036138/disclaimerspopup.aspx.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32226618      PMCID： PMC7098668          DOI： 10.1002/cld.899

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  11 in total

Review 1.  Beneficial cardiovascular pleiotropic effects of statins.

Authors:  Jean Davignon
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

2.  Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

Authors:  K D S Watt; R A Pedersen; W K Kremers; J K Heimbach; M R Charlton
Journal:  Am J Transplant       Date:  2010-05-10       Impact factor: 8.086

3.  Nonalcoholic fatty liver disease is associated with coronary artery calcification.

Authors:  Donghee Kim; Su-Yeon Choi; Eun Ha Park; Whal Lee; Jin Hwa Kang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sook Hyang Jeong; Dong Ho Lee; Hyo-suk Lee; Joseph Larson; Terry M Therneau; W Ray Kim
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

4.  Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.

Authors:  Samarth S Patel; Luis A Guzman; Fei-Pi Lin; Taylor Pence; Trevor Reichman; Binu John; Francesco S Celi; Erika Liptrap; Chandra Bhati; Mohammad S Siddiqui
Journal:  Liver Transpl       Date:  2018-07       Impact factor: 5.799

5.  Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.

Authors:  Yi-Wen Huang; Chia-Long Lee; Sien-Sing Yang; Szu-Chieh Fu; Yun-Yi Chen; Ting-Chuan Wang; Jui-Ting Hu; Ding-Shinn Chen
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

6.  Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.

Authors:  Arpan Mohanty; Janet P Tate; Guadalupe Garcia-Tsao
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

7.  OPTN/SRTR 2017 Annual Data Report: Liver.

Authors:  W R Kim; J R Lake; J M Smith; D P Schladt; M A Skeans; S M Noreen; A M Robinson; E Miller; J J Snyder; A K Israni; B L Kasiske
Journal:  Am J Transplant       Date:  2019-02       Impact factor: 8.086

8.  Coronary artery disease in decompensated patients undergoing liver transplantation evaluation.

Authors:  Samarth S Patel; Eiman Nabi; Luis Guzman; Antonio Abbate; Chandra Bhati; Richard T Stravitz; Trevor Reichman; Scott C Matherly; Carolyn Driscoll; Hannah Lee; Velimir A Luketic; Richard K Sterling; Arun J Sanyal; Vaishali Patel; Marlon Levy; Mohammad Shadab Siddiqui
Journal:  Liver Transpl       Date:  2018-03       Impact factor: 5.799

9.  An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Authors:  Armando Tripodi; Massimo Primignani; Veena Chantarangkul; Alessandra Dell'Era; Marigrazia Clerici; Roberto de Franchis; Massimo Colombo; Pier Mannuccio Mannucci
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

10.  Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network.

Authors:  Mark W Russo; Jay H Hoofnagle; Jiezhun Gu; Robert J Fontana; Huiman Barnhart; David E Kleiner; Naga Chalasani; Herbert L Bonkovsky
Journal:  Hepatology       Date:  2014-05-13       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.